Table: begin end state 1 42 cytoplasmic 43 62 transmembrane 63 67 non-cytoplasmic 68 88 transmembrane 89 113 cytoplasmic 114 139 transmembrane 140 150 non-cytoplasmic 151 170 transmembrane 171 177 cytoplasmic 178 200 transmembrane 201 219 non-cytoplasmic 220 245 transmembrane 246 265 cytoplasmic 266 289 transmembrane 290 308 non-cytoplasmic 309 331 transmembrane 332 356 cytoplasmic 357 380 transmembrane 381 385 non-cytoplasmic 386 407 transmembrane 408 428 cytoplasmic 429 448 transmembrane 449 453 non-cytoplasmic 454 472 transmembrane 473 494 cytoplasmic
Input: >AO353_24335 FitnessBrowser__pseudo3_N2E3:AO353_24335 MKKQKIQSLSAVQCGSELKDRSNWLDSHESGYSKHLKKRHVQMMALGGAIGTGLFLGAGA RLQIAGPALAVIYLVCGIFAFFILRALGELVMHRPSSGSFVSYTREFMGERASFVAGWMY FVVWALTGVVDITAIAIYMKYWSVFSDVPQWVFALSALGVVTLMNMVGVKWFGEMEFWFA VIKVAAISIFLVIGSFFFATGHEVAGHIPGLHLITDNGGIFPHGLLPAIIIVQGVIFAYA SIELVGTAAGETADARKVIPKAINGVIWRISLFYVGSVFLLVTVLPWTAYSANVSPFVTF FEALGVPGIGSVMNIVVMTAALSSLNSGLYATGRVLRSLAMGGSAPKMFKRMSSQGVPYM GILVTMGINVFGVVLNFLIPAQLFELLLNLVSLGIISTWAFIVLSQINYRRAVKRGEVEM VSFRMPGAPFTSWLTLVFLLVVLVLLAFDYPNGTYTVLSIPLVAGALMLGWSKAVRSKAK GSEEIKSDPSHVGA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server